Cell therapy weekly: CAR influence on T-cells key to improving immunotherapy
This week: Astrocytes produced from embryonic stem cells in 2 weeks, myotubular myopathy treatment receives FDA RMAT and new insight into immunomodulatory mechanism of action of extracellular vesicles.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>